Iterum Therapeutics plc (NASDAQ: ITRM)
$1.30
-0.2800 ( -17.70% ) 599.2K
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Market Data
Open
$1.30
Previous close
$1.58
Volume
599.2K
Market cap
$22.27M
Day range
$1.29 - $1.64
52 week range
$0.62 - $2.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 11 | Jun 26, 2024 |
8-k | 8K-related | 12 | Jun 21, 2024 |
8-k | 8K-related | 12 | May 31, 2024 |
10-q | Quarterly Reports | 83 | May 13, 2024 |
8-k | 8K-related | 13 | May 13, 2024 |
8-k | 8K-related | 11 | May 10, 2024 |
8-k | 8K-related | 12 | Apr 29, 2024 |
def | Proxies and info statements | 8 | Apr 26, 2024 |
ars | Annual reports | 1 | Apr 26, 2024 |
8-k | 8K-related | 11 | Apr 05, 2024 |